Category: Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm

  1. Biotech Movers: NeuroDerm Shares Soar on Sale to Japanese Firm  TheStreet.com
  2. Lilly and Nektar Therapeutics Announce Alliance to Develop and Commercialize NKTR-358, A Novel Autoimmune …  PR Newswire (press release)
  3. Lilly pays Nektar $150M upfront to buy into phase 1 drug with broad immune and inflammatory applications  FierceBiotech
  4. Full coverage

from Business – Google News https://www.thestreet.com/story/14239748/1/biotech-movers-neuroderm-shares-soar-on-sale-to-japanese-firm.html

Advertisements